Nephrol Dial Transplant (1999) 14: 2119-2129
© 1999 European Renal Association-European Dialysis and Transplant Association
Molecular Basis of Renal Disease
Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane
1 Department of Pediatrics and 2 Department of Biochemistry, University of Nijmegen, Nijmegen, The Netherlands
Correspondence and offprint requests to: Dr L. P. van den Heuvel, Department of Pediatrics, University Hospital Nijmegen, Box 9101, 6500 HB Nijmegen, The Netherlands.
Abstract
As the first barrier to be crossed on the way to urinary space, the glomerular basement membrane (GBM) plays a key role in renal function. The permeability of the GBM for a given molecule is highly dependent on its size, shape and charge. As early as 1980, the charge-selective permeability was demonstrated to relate to the electrostatic properties of covalently bound heparan sulfates (HS) within the GBM. Since the identification of perlecan as a heparan sulfate proteoglycan (HSPG) of basement membranes, the hypothesis that perlecan could be a crucial determinant of GBM permselectivity received considerable attention. In addition to perlecan, the GBM also contains other HSPG species, one of which was identified as agrin. The high local expression of agrin in the GBM, together with the presence of agrin receptors at the cell–matrix interface, suggests that this HSPG contributes to glomerular function in multiple ways. Here, we review the current knowledge regarding the structure and functions of HSPGs in the GBM, and discuss how these molecules could be involved in various glomerular diseases. Possible directions for future investigation are suggested.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. W. A. M. Celie, R. M. Reijmers, E. M. Slot, R. H. J. Beelen, M. Spaargaren, P. M. ter Wee, S. Florquin, and J. van den Born Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria Am J Physiol Renal Physiol, January 1, 2008; 294(1): F253 - F263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J.M. Wijnhoven, J. F.M. Lensen, R. G.P. Wismans, D. J. Lefeber, A. L.W.M.M. Rops, J. van der Vlag, J. H.M. Berden, L. P.W.J. van den Heuvel, and T. H. van Kuppevelt Removal of Heparan Sulfate from the Glomerular Basement Membrane Blocks Protein Passage J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3119 - 3127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sawai, M. Mukoyama, K. Mori, M. Kasahara, M. Koshikawa, H. Yokoi, T. Yoshioka, Y. Ogawa, A. Sugawara, H. Nishiyama, et al. Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1363 - F1372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Harvey, G. Jarad, J. Cunningham, A. L. Rops, J. van der Vlag, J. H. Berden, M. J. Moeller, L. B. Holzman, R. W. Burgess, and J. H. Miner Disruption of Glomerular Basement Membrane Charge through Podocyte-Specific Mutation of Agrin Does Not Alter Glomerular Permselectivity Am. J. Pathol., July 1, 2007; 171(1): 139 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Harvey and J. H. Miner Breaking Down the Barrier: Evidence against a Role for Heparan Sulfate in Glomerular Permselectivity J. Am. Soc. Nephrol., March 1, 2007; 18(3): 672 - 674. [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Kim, I-H. Liu, Y. Song, J.-A. Lee, W. Halfter, R. J. Balice-Gordon, E. Linney, and G. J. Cole Agrin is required for posterior development and motor axon outgrowth and branching in embryonic zebrafish Glycobiology, February 1, 2007; 17(2): 231 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bjornson Granqvist, K. Ebefors, M. A. Saleem, P. W. Mathieson, B. Haraldsson, and J. S. Nystrom Podocyte proteoglycan synthesis is involved in the development of nephrotic syndrome Am J Physiol Renal Physiol, October 1, 2006; 291(4): F722 - F730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Hunt, M. R. Pollak, and B. M. Denker Cultured Podocytes Establish a Size-Selective Barrier Regulated by Specific Signaling Pathways and Demonstrate Synchronized Barrier Assembly in a Calcium Switch Model of Junction Formation J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1593 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Morita, A. Yoshimura, K. Inui, T. Ideura, H. Watanabe, L. Wang, R. Soininen, and K. Tryggvason Heparan Sulfate of Perlecan Is Involved in Glomerular Filtration J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1703 - 1710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tryggvason and J. Wartiovaara How Does the Kidney Filter Plasma? Physiology, April 1, 2005; 20(2): 96 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Pavenstadt, W. Kriz, and M. Kretzler Cell Biology of the Glomerular Podocyte Physiol Rev, January 1, 2003; 83(1): 253 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Joosten, M. G. A. van Dixhoorn, M. C. Borrias, H. Benediktsson, P. A. van Veelen, C. van Kooten, and L. C. Paul Antibody Response Against Perlecan and Collagen Types IV and VI in Chronic Renal Allograft Rejection in the Rat Am. J. Pathol., April 1, 2002; 160(4): 1301 - 1310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Yan, J. I. Clark, T. N. Wight, and E. H. Sage Alterations in the lens capsule contribute to cataractogenesis in SPARC-null mice J. Cell Sci., January 7, 2002; 115(13): 2747 - 2756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. I. Raats, J. van den Born, M. A. H. Bakker, B. Oppers-Walgreen, B. J. M. Pisa, H. B. P. M. Dijkman, K. J. M. Assmann, and J. H. M. Berden Expression of Agrin, Dystroglycan, and Utrophin in Normal Renal Tissue and in Experimental Glomerulopathies Am. J. Pathol., May 1, 2000; 156(5): 1749 - 1765. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Chen, L. Paka, Y. Kako, P. Singhal, W. Duan, and S. Pillarisetti A Protective Role for Kidney Apolipoprotein E. REGULATION OF MESANGIAL CELL PROLIFERATION AND MATRIX EXPANSION J. Biol. Chem., December 21, 2001; 276(52): 49142 - 49147. [Abstract] [Full Text] [PDF]
|
|